Physician profile
Jade Jones
NPI 1447771787
$4,214.25
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,663 · 2022: $2,410 · 2023: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,103.65 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $716.67 | 2021-2023 | Abilify Maintena, Rexulti, Nuedexta |
| Alkermes, INC. | $428.61 | 2021-2023 | Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $324.67 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $208.12 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $183.26 | 2021-2022 | |
| Neos Therapeutics, LP | $154.70 | 2022-2023 | Adzenys Xr-Odt |
| Avanir Pharmaceuticals, INC. | $150.99 | 2021-2022 | |
| Corium, LLC | $146.25 | 2022 | |
| Almatica Pharma LLC | $137.10 | 2022 | |
| Lundbeck LLC | $131.14 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $123.35 | 2021-2022 | |
| Eisai INC. | $101.20 | 2021 | |
| Bausch Health US, LLC | $84.47 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $51.63 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $43.29 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $40.98 | 2022 | |
| Aytu Biopharma, INC. | $22.75 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.59 | 2022 | |
| Harmony Biosciences LLC | $17.16 | 2021 | |
| Adlon Therapeutics L.P. | $13.78 | 2021 | |
| Axsome Therapeutics, INC. | $12.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.